Hennion & Walsh Asset Management, Inc. Immunocore Holdings PLC Transaction History
Hennion & Walsh Asset Management, Inc.
- $2.59 Billion
- Q3 2025
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 62,662 shares of IMCR stock, worth $2.25 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
62,662
Previous 66,780
6.17%
Holding current value
$2.25 Million
Previous $2.1 Million
8.64%
% of portfolio
0.09%
Previous 0.09%
Shares
8 transactions
Others Institutions Holding IMCR
# of Institutions
147Shares Held
46.9MCall Options Held
325KPut Options Held
1.74M-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.06MShares$254 Million0.16% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$175 Million2.36% of portfolio
-
Wellington Management Group LLP Boston, MA4.78MShares$172 Million0.03% of portfolio
-
Primecap Management CO Pasadena, CA3.75MShares$135 Million0.11% of portfolio
-
Bellevue Group Ag Kuesnacht, V82.8MShares$101 Million2.17% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.58B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...